Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Envista Holdings Co. (NYSE:NVST – Get Rating) by 10.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,140 shares of the company's stock after buying an additional 5,639 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS's holdings in Envista were worth $2,881,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. CI Investments Inc. boosted its stake in shares of Envista by 8,922.2% during the first quarter. CI Investments Inc. now owns 812 shares of the company's stock valued at $40,000 after purchasing an additional 803 shares during the period. Covestor Ltd purchased a new stake in shares of Envista during the fourth quarter valued at $43,000. Wakefield Asset Management LLLP purchased a new stake in shares of Envista during the first quarter valued at $231,000. Hotaling Investment Management LLC raised its holdings in shares of Envista by 6.1% in the first quarter. Hotaling Investment Management LLC now owns 5,251 shares of the company's stock valued at $256,000 after acquiring an additional 300 shares in the last quarter. Finally, Vestmark Advisory Solutions Inc. raised its holdings in shares of Envista by 4.9% in the first quarter. Vestmark Advisory Solutions Inc. now owns 5,514 shares of the company's stock valued at $269,000 after acquiring an additional 259 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on NVST shares. Piper Sandler upgraded Envista from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $40.00 to $46.00 in a report on Monday, August 29th. TheStreet downgraded Envista from a "b" rating to a "c+" rating in a report on Friday, June 17th. Robert W. Baird downgraded Envista from an "outperform" rating to a "neutral" rating and decreased their price objective for the company from $54.00 to $46.00 in a report on Tuesday, June 14th. Morgan Stanley decreased their price objective on Envista from $53.00 to $49.00 and set an "overweight" rating for the company in a report on Thursday, August 4th. Finally, Stifel Nicolaus decreased their price objective on Envista from $55.00 to $50.00 in a report on Friday, June 17th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $46.86.

Envista Stock Performance

Envista Company Profile

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.

Featured Articles

• Get a free copy of the StockNews.com research report on Envista (NVST)
• 3 High Margin Chipmakers Bound to Recover
• 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
• REV Group Has A Deep Moat In The World Of EVs
• Is G-III Apparel Group, Ltd. A Value Trap?
• Bank Of America Sees Upside In These 2 European Alcohol Stocks

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.